Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Take daily with breakfast
Compare to
The pineal/melatonin and antioxidant effects are better established
The REDEFINE clinical trial program has established that: Cagrilintide 2.4 mg + Semaglutide 2.4 mg weekly produces superior weight loss compared to either agent alone The combination achieved 22.7% mean weight reduction at 68 weeks Side effect profiles were manageable with proper dose escalation The amylin + GLP-1 agonist combination demonstrated synergistic effects This validated combination demonstrates that pairing cagrilintide with incretin-based therapies can work effectively
Phase 2 NEJM 2023: 24.2% at 48 weeks
Working closely with a knowledgeable provider gives you the best chance to find the right peptide protocol for your unique needs
